News

U.S. trade regulators have launched ‌a probe into ‌Samsung Electronics' memory chips and ​products sold by Google, Nvidia, Broadcom and Super Micro Computer that use ‌them ⁠after a complaint by Netlist alleging infringement ⁠of its patents. California-based Netlist has accused Samsung ​and its ​U.S. ​units of ‌infringing its patents on dynamic random access memory, a type of chip that temporarily stores data ‌for processors ​and is a ​critical ​component in the ‌servers powering the ​AI ​boom, the U.S. International Trade Commission (USITC) said ​on ‌Wednesday.

Investors were set to parse signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

Optimus is the second-biggest concern, with investors seeking production and deployment updates.

New arrivals on the stock market often generate plenty of early hype. Their average early returns are less exciting.

Multiple securities class action lawsuits have been filed against First Solar (NasdaqGS:FSLR). The suits allege materially misleading statements about U.S. tariff policy and production utilization. Plaintiffs claim the company understated the impact of production relocation and facility underutilization on its outlook. First Solar is a major U.S. solar module producer, and the new wave of litigation puts its disclosures around tariff exposure and manufacturing utilization under closer...

The technology sector was dragging markets on Wall Street and around the world mostly lower Thursday and oil prices fell despite a flurry of military strikes between the U.S. and Iran. Chip and memory companies were getting hit the hardest, with Western Digital and SanDisk leading the way down with losses of more than 7%. Despite the heavy investment in artificial intelligence, investors remain concerned that stock prices have shot too high and that the demand may not be sustainable if AI doesn’t deliver as much profit and productivity as expected.

UAL’s adjusted earnings and revenue both came in ahead of consensus estimates, with operating revenue rising 16% year-over-year.

TeraWulf Co-founder and CTO/COO Nazar Khan joins use to discuss the ramifications of NY’s data center moratorium for the company’s NY campuses, financing for its Anthropic deal, and why it’s…

IBM's Earnings Fallout Continues as Oppenheimer Downgrades the Stock

Rumors used to die quietly. Now they move markets before a company can even pick up the phone, and the bill lands in your brokerage account long before the truth catches up. That is the tax every owner of a speculative stock pays, whether they budget for it or not. The electric vehicle business has ...

(Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexe

Shares of Musk’s rocket and telecom company slipped under the $135 debut price this week, and selling hasn’t even started yet.

The stock has shed about 34% from its peak, pulling SpaceX's market cap down to roughly $1.75 trillion from above $2.6 trillion last month

OpenAI’s struggles could cause the AI bubble to burst, bringing down with it much more than the company’s hardware division.

(Updates with index/price moves, macroeconomic/rates data, and company/geopolitical news from the fi

The selloff extends well beyond Dell. Hewlett Packard Enterprise is sliding roughly 8% and Super Micro Computer is off around 5%, confirming the move is concentrated in high-beta AI hardware names rather than broad technology. The Nasdaq-100 ETF (QQQ) is down about 1% on the session.

SpaceX stock continued its multi-week downtrend Wednesday, officially falling below its IPO listing price.

Shares slipped 2.5% to $132.72 in recent trading. Over the past month they have edged lower; even SpaceX’s addition to the Nasdaq-100 index didn’t boost them. SpaceX is hardly the first big IPO to struggle in early days or weeks of trading.

Shares in Elon Musk’s SpaceX have fallen below their initial public offering (IPO) price for the first time since the rocket company went public.

All three major US stock indexes were up in late-morning trading Wednesday, as technology stocks led

Lucid confirms working with AlixPartners but calls bankruptcy rumors "completely false."

OpenAI says it sees no evidence supporting Apple's lawsuit over alleged trade-secret theft.

Dell has emerged as an unexpected beneficiary after IBM's results highlighted a growing enterprise shift toward AI infrastructure investments.

OpenAI plans a screen-free AI home device while Apple seeks an injunction that could delay its rollout.

Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business. CEO Gail Boudreaux said the insurer’s Medicaid results were roughly what it expected, but the company is leaving the District of Columbia’s Medicaid market and plans to exit others over the next year to 18 months.

Shares closed just $1 above the IPO price as Wall Street remains broadly bullish despite continued selling pressure.

OpenAI still plans a year-end device reveal, but Apple's lawsuit, ecosystem strength and rising component costs may complicate its hardware push.

The judge ruled that federal law protects Apple from claims tied to content uploaded by users.

An EV blog reported Lucid was weighing Chapter 11 or going private on the advice of AlixPartners — Lucid called the claims false

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.